Patrick G. Enright, Director, 10% Owner at Vera Therapeutics, Inc. (VERA), bought 1,714,285 shares at $7.00 ($12.0M) on 2023-02-06, disclosed to the SEC on 2023-02-08.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Something here stands out, but not much.
| Filing → |
| ZBIO | BUY | 2025-10-14 | $2.5M | — | Filing → |
| VERA | BUY | 2025-06-25 | $10.6M | — | Filing → |
| BIOA | BUY | 2024-09-27 | $7.2M | — | Filing → |